Suramin inhibits osteoarthritic cartilage degradation by increasing extracellular levels of chondroprotective tissue inhibitor of metalloproteinases 3 (TIMP-3)
Osteoarthritis is a common degenerative joint disease for which no disease-modifying drugs are currently available. Attempts to treat the disease with small molecule inhibitors of the metalloproteinases that degrade the cartilage matrix have been hampered by a lack of specificity. We aimed to inhibi...
Main Authors: | Chanalaris, A, Doherty, C, Marsden, B, Bambridge, G, Wren, S, Nagase, H, Troeberg, L |
---|---|
Format: | Journal article |
Udgivet: |
American Society for Pharmacology and Experimental Therapeutics
2017
|
Lignende værker
-
Engineered tissue inhibitor of metalloproteinases-3 variants resistant to endocytosis have prolonged chondroprotective activity
af: Doherty, C, et al.
Udgivet: (2016) -
Interleukin 13 (IL-13)-regulated expression of the chondroprotective metalloproteinase ADAM15 is reduced in aging cartilage
af: Yang, CY, et al.
Udgivet: (2020) -
Fibronectin fragments induce aggrecan degradation in human cartilage and are increased in osteoarthritic cartilage
af: Sofat, N, et al.
Udgivet: (2007) -
Calcium pentosan polysulfate is a multi-functional aggrecanase inhibitor that enhances interaction with endogenous TIMP-3 in cartilage
af: Troeberg, L, et al.
Udgivet: (2009) -
Heparan sulfate proteoglycan synthesis is dysregulated in human osteoarthritic cartilage
af: Chanalaris, A, et al.
Udgivet: (2018)